Conway P - Search Results

1

Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data.

Bannister CA, Orr JG, Reynolds AV, Hudson M, Conway P, Radwan A, Morgan CL, Currie CJ. Bannister CA, et al. Among authors: conway p. Clin Ther. 2016 May;38(5):1081-1089.e4. doi: 10.1016/j.clinthera.2016.03.033. Epub 2016 Apr 30. Clin Ther. 2016. PMID: 27136714 Clinical Trial.

2

Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United Kingdom.

Berni E, Murphy D, Whitehouse J, Conway P, Di Maggio P, Currie CJ, Poole C. Berni E, et al. Among authors: conway p. Curr Med Res Opin. 2018 Nov;34(11):2001-2008. doi: 10.1080/03007995.2018.1499506. Epub 2018 Aug 13. Curr Med Res Opin. 2018. PMID: 29995455 Clinical Trial.

3

Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study.

Morgan CL, Jenkins-Jones S, Knaggs R, Currie C, Conway P, Poole CD, Berni E. Morgan CL, et al. Among authors: conway p. Clin Ther. 2021 Jun;43(6):968-989. doi: 10.1016/j.clinthera.2021.03.021. Epub 2021 Apr 27. Clin Ther. 2021. PMID: 33931241

4

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality.

Currie CJ, Poole CD, Conway P. Currie CJ, et al. Among authors: conway p. Heart. 2008 Apr;94(4):457-62. doi: 10.1136/hrt.2007.118794. Epub 2007 Aug 29. Heart. 2008. PMID: 17761503

5

The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).

Berni ER, Jones BI, Berni TR, Whitehouse J, Hudson M, Orr J, Conway P, Amlani B, Currie CJ. Berni ER, et al. Among authors: conway p. PLoS One. 2019 Oct 3;14(10):e0223253. doi: 10.1371/journal.pone.0223253. eCollection 2019. PLoS One. 2019. PMID: 31581237 Free PMC article.

6

An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice.

Poole CD, Conway P, Currie CJ. Poole CD, et al. Among authors: conway p. Rheumatology (Oxford). 2009 Jan;48(1):78-82. doi: 10.1093/rheumatology/ken415. Rheumatology (Oxford). 2009. PMID: 19056800

7

Descriptive epidemiology of hospitalisation for psoriasis.

Conway P, Currie CJ. Conway P, et al. Curr Med Res Opin. 2008 Dec;24(12):3487-91. doi: 10.1185/03007990802583563. Curr Med Res Opin. 2008. PMID: 19032130

8

The relationship between self-reported severe pain and measures of socio-economic disadvantage.

Morgan CL, Conway P, Currie CJ. Morgan CL, et al. Among authors: conway p. Eur J Pain. 2011 Nov;15(10):1107-11. doi: 10.1016/j.ejpain.2011.04.010. Epub 2011 May 26. Eur J Pain. 2011. PMID: 21620747

9

Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom.

McEwan P, Baboolal K, Conway P, Currie CJ. McEwan P, et al. Among authors: conway p. Clin Ther. 2005 Nov;27(11):1834-46. doi: 10.1016/j.clinthera.2005.11.002. Clin Ther. 2005. PMID: 16368455

10

Characterisation and comparison of health-related quality of life for patients with renal failure.

Lee AJ, Morgan CL, Conway P, Currie CJ. Lee AJ, et al. Among authors: conway p. Curr Med Res Opin. 2005 Nov;21(11):1777-83. doi: 10.1185/030079905X65277. Curr Med Res Opin. 2005. PMID: 16307698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters